光热治疗
癌症研究
热疗
热休克蛋白
细胞毒性
肺癌
化学
Hsp90抑制剂
癌细胞
背景(考古学)
热休克蛋白90
细胞
氧化应激
癌症治疗
癌症治疗
癌症
肺癌的治疗
伴侣(临床)
细胞生长
后天抵抗
抗药性
肿瘤细胞
热休克蛋白27
靶向治疗
免疫系统
免疫疗法
细胞培养
热疗
作者
Huifang Hao,Zhe Yu,Cheng Cao,Yingao Jiao,Yu Cao,Xinyuan Cui,Yan Gao,Dengyao Gao,Shengsheng Cui,Chenyu Wang,Yanlei Liu
标识
DOI:10.1021/acsanm.6c00609
摘要
Non-small cell lung cancer (NSCLC) treatment is often compromised by acquired resistance and, in the context of photothermal therapy (PTT), by tumor thermotolerance─a protective stress response mediated by the molecular chaperone heat shock protein 90 (HSP90). To address this dual challenge, we developed a multifunctional nanoplatform (Cu 9 S 8 @Lum NPs) that synergistically integrates NIR-II PTT with HSP90 inhibition. This nanosystem is based on a Cu 9 S 8 nanocore with high photothermal conversion efficiency, loaded with the HSP90 inhibitor Luminespib and designed for pH-responsive drug release. This spatiotemporally coordinated strategy enables concurrent tumor hyperthermia and molecular interference with the heat-shock defense mechanism. In vitro, the nanoparticles effectively suppressed HSP90 expression, exacerbated cellular oxidative stress, and induced mitochondrial apoptosis, resulting in markedly enhanced cytotoxicity compared to PTT alone. In vivo, the nanoplatform demonstrated effective tumor accumulation and, under mild NIR-II irradiation, achieved significant tumor growth inhibition in a syngeneic model. This work presents a mechanism-informed nanomaterial strategy to overcome thermotolerance in NSCLC, advancing the development of synergistic cancer nanotherapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI